UK markets close in 6 hours 16 minutes

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3100+0.1400 (+6.45%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-15,426
-15,426
-8,230
-24,384
-1,148
Depreciation & amortisation
5.468
5.468
2.135
2.468
2.321
Stock-based compensation
2,566
2,566
624.069
218.983
0
Change in working capital
1,653
1,653
195.206
-391.035
165.848
Accounts payable
2,434
2,434
1,132
-106.061
-3.83
Other working capital
-11,424
-11,424
-7,408
-1,590
-404.694
Other non-cash items
-
-
100
118.157
-
Net cash provided by operating activities
-11,371
-11,371
-7,408
-1,589
-404.694
Cash flows from investing activities
Investments in property, plant and equipment
-52.089
-52.089
-
-0.802
-
Net cash used for investing activities
-52.089
-52.089
0
-0.802
0
Cash flows from financing activities
Debt repayment
0
0
-50
0
-
Common stock issued
15,696
15,696
3,389
18,649
0
Common stock repurchased
0
0
-99.963
0
-
Other financing activities
-234.616
-234.616
-6.724
-
-
Net cash used provided by (used for) financing activities
15,464
15,464
3,232
18,849
0
Net change in cash
4,073
4,073
-4,208
17,253
-342.928
Cash at beginning of period
13,437
13,437
17,644
391.086
734.014
Cash at end of period
17,510
17,510
13,437
17,644
391.086
Free cash flow
Operating cash flow
-11,371
-11,371
-7,408
-1,589
-404.694
Capital expenditure
-52.089
-52.089
-
-0.802
-
Free cash flow
-11,424
-11,424
-7,408
-1,590
-404.694